Quantum BioPharma Says FDA Cleared IND Application For Lucid-MS In Multiple Sclerosis, Enabling Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Share
Why It Matters
Quantum BioPharma got permission to test a new medicine called Lucid-MS. This is a big step forward, and now we can watch if the drug actually works in real patient tests.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.